Testing effectiveness (Phase 2)WithdrawnNCT00837174What this trial is testingRelapsed and/or Refractory Non-Hodgkin Lymphoma StudyWho this might be right forNon-Hodgkin Lymphoma The Methodist Hospital Research Institute
Testing effectiveness (Phase 2)UnknownNCT04610970What this trial is testingTQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL）Who this might be right forDiffuse Large B-cell Lymphoma Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 93
Testing effectiveness (Phase 2)Active Not RecruitingNCT05283720What this trial is testingEvaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin LymphomaWho this might be right forNon-Hodgkin Lymphoma Genmab 264
Early research (Phase 1)Looking for participantsNCT05131022What this trial is testingNX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesWho this might be right forChronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)Diffuse Large B Cell Lymphoma (DLBCL)+6 more Nurix Therapeutics, Inc. 572
Testing effectiveness (Phase 2)Study completedNCT00795769What this trial is testingOndansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+101 more Fred Hutchinson Cancer Center 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06886139What this trial is testingTRS005 in Patients With CD20-positive R/R DLBCL.Who this might be right forCD20-positive Diffuse Large B-Cell Lymphoma Zhejiang Teruisi Pharmaceutical Inc. 139
Testing effectiveness (Phase 2)Ended earlyNCT01159067What this trial is testingDeferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron OverloadWho this might be right forIron OverloadAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+99 more City of Hope Medical Center 1
Early research (Phase 1)Looking for participantsNCT05887167What this trial is testingFeasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological MalignanciesWho this might be right forHematologic MalignancyLarge B-cell LymphomaAcute Lymphoblastic Leukemia+3 more Joshua Sasine, MD, PhD 20
Testing effectiveness (Phase 2)Study completedNCT00005631What this trial is testingRituximab and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Large Cell LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02624492What this trial is testingTo Determine the Dose of BI 836826-GemOx and the Efficacy of BI 836826-GemOx Versus R-GemOx in Patients With Relapsed/Refractory DLBCLWho this might be right forLymphoma, Large B-Cell, Diffuse Boehringer Ingelheim 21
Testing effectiveness (Phase 2)Study completedNCT06539195What this trial is testingDZD8586 in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (TAI-SHAN9)Who this might be right forDiffuse Large B Cell Lymphoma Dizal Pharmaceuticals 59
Early research (Phase 1)Study completedNCT03440567What this trial is testingAvelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Mantle Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+2 more City of Hope Medical Center 16
Not applicableLooking for participantsNCT06131801What this trial is testingPharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a SolutionWho this might be right forHematologic MalignancyLeukemiaLymphoma+16 more Children's Hospital Medical Center, Cincinnati 30
Early research (Phase 1)Ended earlyNCT00103272What this trial is testing17-N-Allylamino-17-Demethoxygeldanamycin and Bortezomib in Treating Patients With Relapsed or Refractory Hematologic CancerWho this might be right forAdult Acute Basophilic LeukemiaAdult Acute Eosinophilic LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)+32 more National Cancer Institute (NCI) 74
Early research (Phase 1)Study completedNCT02431988What this trial is testingEvaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic TransplantationWho this might be right forDiffuse Large B-Cell Lymphoma University College, London 10
Early research (Phase 1)Study completedNCT01943682What this trial is testingSafety Study of CPX-351 in Children With Relapsed Leukemia or LymphomaWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaBurkitt Lymphoma+5 more Children's Hospital Medical Center, Cincinnati 27
Early research (Phase 1)Looking for participantsNCT07570017What this trial is testingRocbrutinib Combined With R-GemOx in Patients With Relapsed or Refractory Diffuse Large B-cell LymphomaWho this might be right forDLBCL Guangzhou Lupeng Pharmaceutical Company LTD. 42
Not applicableStudy completedNCT04697160What this trial is testingObservational Retrospective Cohort Study of Systemic Therapies for R/R DLBCLWho this might be right forDiffuse Large B Cell Lymphoma MorphoSys AG 3,573
Testing effectiveness (Phase 2)Study completedNCT00005040What this trial is testingArsenic Trioxide in Treating Patients With Relapsed or Refractory Non- Hodgkin's LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Active Not RecruitingNCT05253118What this trial is testingRelapsed or Refractory Primary Diffuse Large B-cell Lymphoma (DLBCL) of the Central Nervous System (CNS)Who this might be right forDLBCL Seoul National University Hospital 28